This article first appeared on GuruFocus .
-
Revenue:INR 79.45 crores for Q1 FY27, up 8.9% sequentially and 19.7% year-over-year.
-
EBITDA:INR 16.87 crores, with EBITDA margin at 21.2%; EBITDA grew fourfold compared to the same quarter last year.
-
Normalized PAT:INR 16.909 crores, compared to INR 11.51 crores in the previous quarter.
-
PAT (including exceptional items):INR 14.22 crores, compared to INR 9.93 crores in the previous quarter.
-
Cash and Cash Equivalents:INR 184.8 crores at the end of the quarter.
-
Warning! GuruFocus has detected 6 Warning Signs with BOM:532348.
-
Is BOM:532348 fairly valued? Test your thesis with our free DCF calculator.
Release Date: August 06, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Revenue grew 8.9% sequentially and 19.7% year-over-year, with EBITDA margin at 21.2% and EBITDA up fourfold from the same quarter last year.
-
Strong balance sheet with cash and cash equivalents of INR 184.8 crores, providing flexibility for future investments.
-
Renewed managed services and software license agreements with a tier-one operator in the Middle East, and secured new business assurance and fraud management deals in Europe and Asia Pacific.
-
Partner ecosystem management (PEM) product is gaining traction, with stronger deal flow and a key renewal, positioning it as a significant growth contributor.
-
Management is considering structural balance sheet improvements, including capital reduction and ESOPs, to reward performance and enhance shareholder value.
Negative Points
-
Management acknowledged a slowdown in order closures due to geopolitical tensions, particularly in the Middle East, with contracts taking longer to close (shifting by a month or two).
-
The company is facing cautious buying and extended timelines in the Asia Pacific region, and Africa is slowing down, impacting overall deal flow.
-
Management declined to provide specific guidance on pipeline size or order backlog, citing competitive sensitivity, which may frustrate investors seeking more transparency.
-
R&D intensity is expected to increase, with plans to reinvest in AI and new initiatives, which could pressure near-term margins despite current profitability.
-
Litigation related to legacy contracts is ongoing, with one major case still unresolved and expected to take time, potentially affecting future recoveries.
Q & A Highlights
Q: Has the board considered reducing equity capital and writing it off against pending losses to make the company leaner? A: Nisha Dutt (MD & CEO) confirmed that the board discussed this suggestion at the meeting held the day before. The management is acutely aware that structural balance sheet changes are needed now that the turnaround is complete. They plan to appoint a consultant to figure out the best way to proceed while protecting shareholder interests. This will be a long-term process requiring board, shareholder, and NCLT approvals, but it is strongly under consideration.
Q: What is the size of the executable order pipeline for this year, and what is the total value of pending order wins? A: Nisha Dutt (MD & CEO) explained that the company aims to maintain a qualified pipeline of at least 3-4 times its annual order intake target. She clarified that the company does not announce every order win, only new logos and material deals. She noted that 70% of revenue is recurring, meaning it is already in the bag at the start of the year, while the remaining 30% comes from new wins. For deals announced last year, the company expects to recognize 30-40% of that value this year.
Q: Where do you see EBITDA margins stabilizing, and what is the variance in margins across contracts? A: Nisha Dutt (MD & CEO) stated that the company has a threshold below which it does not accept contracts, which varies by geography. While margins expanded this quarter, she cautioned that the company will not pursue indefinite margin expansion. The priority is to reinvest in growth initiatives, particularly around AI and product innovation. She indicated margins should remain in the mid-to-high teens ballpark, with a reasonable expansion from last year, but the company will plow back excess cash into the business to win the Gen AI race.
Q: How is the market scenario affecting order closures, and are there delays in the Middle East, US, and Europe? A: Nisha Dutt (MD & CEO) acknowledged some slowdown in order closures due to the Middle East conflict, with contracts taking longer to close, particularly in legal negotiations. She noted that while no deals have been lost, some contracts have shifted by a month or two. The US market is performing better, Europe is okay, but Asia Pacific is also seeing extended timelines. Africa remains slow. She emphasized that the company is focused on ensuring watertight contracts rather than rushing closures.
Q: What is the timeline from contract signing to subscription revenue, and what work has been done to shorten it? A: Nisha Dutt (MD & CEO) explained that the typical cycle from contract signing to subscription revenue is four to five quarters, depending on implementation complexity. However, revenue is recognized during implementation through milestones like BRD and FSD sign-offs. The company's internal goal is to reduce this timeline by one quarter. She noted recent success, with one project completed 45 days ahead of schedule, and the company is working on reusability initiatives to achieve the full quarter reduction.
Q: What is the plan for the ESOP scheme announced, and when will shares be acquired? A: Nisha Dutt (MD & CEO) detailed that the company has approval for 5% ESOP, but is capped at acquiring 2% in a given financial year. The plan is to trigger a postal ballot for shareholder approval within two weeks, then acquire shares from the market at a price calculated based on the last 60 days' trading. Execution is expected around Q3, with allocation to employees required within six months of acquisition. The company will take a loan to fund the acquisition.
Q: Are you seeing any increase in R&D expenses, and where are the investments being directed? A: Nisha Dutt (MD & CEO) confirmed that R&D intensity will increase in coming quarters. R&D spend is divided into engineering and AI engineering. The company is investing in Horizon 1 (making current products Gen AI-enabled), Horizon 2 (expanding portfolio to tackle new fraud types like account takeover and social engineering), and Horizon 3 (experimental bets in areas like satellites and data centers). She noted that people expense will be replaced by token expense as the company uses more AI. The R&D team is approximately 200 people out of a total workforce of around 700.
Q: Are there any recoveries from the earlier Secular contracts that were written off, and will more funds be needed for the Middle East subsidiary? A: Nisha Dutt (MD & CEO) stated that litigation on the Secular contracts is ongoing, with one of three entities already settled. The company is hoping to close the other two this quarter. The second contract is entirely under litigation in the Middle East, which is taking time due to the jurisdiction. Regarding the Middle East subsidiary, Sumit confirmed that no further capital infusion is expected as it is self-sufficient, though the situation remains volatile.
Q: What is the company's vision for the future, and how will it transition from a turnaround story to a growth story? A: Nisha Dutt (MD & CEO) outlined a three-horizon strategy: Horizon 1 focuses on making current products (RA, FM, PEM) fully Gen AI-enabled; Horizon 2 involves expanding the portfolio to address new fraud types; Horizon 3 targets exciting new areas like satellites and data centers. She aims to transition the business split to 60-30-10 across these horizons over the next two years. She acknowledged investor feedback that the company needs to communicate its vision better and committed to activating this in the next quarter.
Q: What is the impact of ForEx gains on the revenue jump from 72.96 crores to 79.45 crores? A: Nisha Dutt (MD & CEO) and Sumit clarified that the rupee depreciation against the dollar contributed approximately 3 crores to the sequential revenue increase. While quarter-on-quarter ForEx gains are minimal, year-on-year there is a significant benefit since the majority of revenue is in foreign currency. The company uses month-average rates for conversion, and the balance sheet will be revalued in Q2.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
